Medication info
Badok Tablet 20 mg (Bazedoxifene Acetate)

Badok Tablet 20 mg (Bazedoxifene Acetate)

Prescription medicationTabletOral
Ingredient · strength
Bazedoxifene Acetate›Strength being verified
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201804106 · Approved 2018.10.17

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily (equivalent to 20mg of bazedoxifene), with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dosage adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • vertebral fractures
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the risk of vertebral fractures. However, a clear effect on non-vertebral fractures has not yet been established. Therefore, this medication primarily aids in reducing the risk of spinal-related fractures and improving bone density. Patients are advised to take this medication regularly and undergo periodic bone density tests.

How to take

Adult dose

Take 1 tablet once daily (equivalent to 20mg of bazedoxifene), with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dosage adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.

Precautions

This medication should only be used in postmenopausal women and should not be administered to premenopausal women, women who may become pregnant, or nursing mothers. This medication may increase the risk of venous thromboembolism; therefore, it should be avoided in patients with a history of thrombosis or those at risk for thrombosis. Particular caution is needed in elderly patients, those who are obese, those who have been immobile for extended periods, those recovering from surgery, and cancer patients, as they are at increased risk for thrombosis. While taking this medication, it is important to regularly move about during long travels to aid blood circulation. Administration should be cautious in patients with severe liver or kidney impairment, and those with significantly elevated triglycerides should also be monitored closely. This medication may cause uterine bleeding; thus, if any bleeding occurs, it is essential to consult a healthcare professional. Symptoms such as facial flushing, leg cramps, drowsiness, and vision disturbances may occur during treatment, and it is advisable to avoid driving or operating machinery if these symptoms arise. This medication should not be given to patients with certain genetic disorders, for example, those who are lactose intolerant. In cases of overdose, no specific antidote exists, and treatment should be symptomatic. Keep this medication out of the reach of children, store it in its original container, and avoid transferring it to another container, as this may degrade its quality. This medication has a low potential for drug interactions, but caution is warranted when taken with drugs that induce certain liver enzymes, as this may alter drug concentrations. If you are pregnant or may become pregnant, you must discontinue this medication immediately as it may harm the fetus. This medication is not for use in children, and elderly patients may use it without dose adjustment, but blood levels may increase depending on liver function changes.

Side effects

  • Venous thromboembolism
  • deep vein thrombosis
  • pulmonary embolism
  • retinal vein thrombosis
  • hypersensitivity
  • drowsiness
  • facial flushing
  • leg cramps
  • dry mouth
  • urticaria
Show 86 more
  • rash
  • itching
  • muscle cramps
  • peripheral edema
  • increased triglycerides
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • decreased vision
  • blurred vision
  • photopsia
  • visual field defect
  • visual impairment
  • dry eye syndrome
  • eyelid edema
  • eyelid spasm
  • eye pain
  • eye swelling
  • death
  • fever
  • generalized edema
  • fatigue
  • fracture
  • myalgia
  • shoulder rotator cuff syndrome
  • spinal stenosis
  • cerebral infarction
  • cerebral hemorrhage
  • pyelonephritis
  • bradycardia
  • respiratory failure
  • biliary stones
  • vomiting
  • gastritis
  • colonic polyps
  • belching
  • allergic reaction
  • chest discomfort
  • leg pain
  • facial edema
  • changes in body temperature sensation
  • lethargy
  • weakness
  • insufficient efficacy
  • dermatitis
  • localized skin reaction
  • increased sweating
  • eczema
  • hair loss
  • back pain
  • arthralgia
  • muscle weakness
  • dizziness
  • pharyngitis
  • bronchitis
  • cystitis
  • upper respiratory infection
  • pneumonia
  • retinal hemorrhage
  • sputum disease
  • cough
  • asthma
  • shortness of breath
  • laryngitis
  • pleural effusion
  • increased alkaline phosphatase
  • liver cyst
  • hepatocellular damage
  • weight gain
  • hyperlipidemia
  • central obesity
  • dysuria
  • abnormal urination
  • renal cyst
  • urinary incontinence
  • vaginal bleeding
  • breast congestion
  • insomnia
  • leukocytosis
  • laceration
  • contusion
  • nausea
  • abdominal pain
  • constipation
  • diarrhea
  • headache
  • palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at a temperature below 25 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.